Cytokine Genetic Variations and Fatigue Among Patients With Breast Cancer | Zendy

Julienne E. Bower | Zendy; Patricia A. Ganz | Zendy; Michael R. Irwin | Zendy; Steven A. Castellon | Zendy; Jesusa M.G. Arevalo | Zendy; Steve W. Cole | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Cytokine Genetic Variations and Fatigue Among Patients With Breast Cancer

Author(s) -

Julienne E. Bower,

Patricia A. Ganz,

Michael R. Irwin,

Steven A. Castellon,

Jesusa M.G. Arevalo,

Steve W. Cole

Publication year - 2013

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2012.46.2143

Subject(s) - medicine , cancer related fatigue , breast cancer , single nucleotide polymorphism , genotyping , allele , cancer , oncology , genotype , gene , genetics , biology

Fatigue is a common adverse effect of cancer treatment and may persist for years after treatment completion. However, risk factors for post-treatment fatigue have not been determined. On the basis of studies suggesting an inflammatory basis for fatigue, this study tested the hypothesis that expression-regulating polymorphisms in proinflammatory cytokine genes would predict post-treatment fatigue in breast cancer survivors.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research